How Prison Shaped a Woman’s Career Path
All this week, WBHM is exploring challenges people confront after being released from Alabama’s prisons. One struggle former inmates face is what to do with their lives once they are released.
For 10 years of her adult life, Jamie Faust was in and out of county jail and federal prison. In 2012 she entered Julia Tutwiler’s Prison for Women as an HIV positive inmate. At the time, HIV inmates were segregated from the general population.
She tells WBHM’s Sarah Delia that living with HIV in prison wasn’t easy, but the experience pushed her to follow a career path she might not have otherwise.
Q&A: How harm reduction can help mitigate the opioid crisis
Maia Szalavitz discusses harm reduction's effectiveness against drug addiction, how punitive policies can hurt people who need pain medication and more.
The Gulf States Newsroom is hiring a Community Engagement Producer
The Gulf States Newsroom is seeking a curious, creative and collaborative professional to work with our regional team to build up engaged journalism efforts.
Gambling bills face uncertain future in the Alabama legislature
This year looked to be different for lottery and gambling legislation, which has fallen short for years in the Alabama legislature. But this week, with only a handful of meeting days left, competing House and Senate proposals were sent to a conference committee to work out differences.
Alabama’s racial, ethnic health disparities are ‘more severe’ than other states, report says
Data from the Commonwealth Fund show that the quality of care people receive and their health outcomes worsened because of the COVID-19 pandemic.
What’s your favorite thing about Alabama?
That's the question we put to those at our recent News and Brews community pop-ups at Hop City and Saturn in Birmingham.
Q&A: A former New Orleans police chief says it’s time the U.S. changes its marijuana policy
Ronal Serpas is one of 32 law enforcement leaders who signed a letter sent to President Biden in support of moving marijuana to a Schedule III drug.
